Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 16,909,961 | $24.23 | $410M | — | — | |
| BHF - Brighthouse Finl | Reduce −4.4% | 3,195,650 | $51.27 | $164M | −145,950 | +$19M | |
| CEIXEUR - Consol Energy | Add +5.8% | 1,812,551 | $65.00 | $118M | +99,830 | +$8M | |
| KD - Kyndryl | Add +24.2% | 9,006,560 | $11.12 | $100M | +1,755,560 | +$40M | |
| TECK - Teck Resources · CL B | Add +3.3% | 2,236,518 | $37.82 | $85M | +72,320 | +$19M | |
| ODP1 - The Odp | Reduce −2.4% | 1,651,440 | $45.54 | $75M | −41,320 | +$16M | |
| CPRI - Capri | Reduce −4.4% | 945,300 | $57.32 | $54M | −43,200 | +$16M | |
| Southwestern Energy | Add +47.4% | 8,991,850 | $5.85 | $53M | +2,890,550 | +$15M | |
| GPN - Global Pmts | Add +73.2% | 473,150 | $99.32 | $47M | +199,910 | +$17M | |
| LIVN - Livanova | Add +3.2% | 838,400 | $55.54 | $47M | +26,000 | +$5M | |
| GLD - Spdr Gold Tr | Reduce −16.2% | 209,541 | $169.64 | $36M | −40,420 | −$3M | |
| SLV - Ishares Silver Tr | Reduce −2.2% | 1,524,010 | $22.02 | $34M | −33,990 | +$6M | |
| THC - Tenet Healthcare | New | 658,900 | $48.79 | $32M | +658,900 | +$32M | |
| WFRD - Weatherford Intl | Reduce −22.6% | 583,725 | $50.92 | $30M | −170,275 | +$5M | |
| CIVI - Civitas Resources | Add +65.8% | 461,398 | $57.93 | $27M | +183,180 | +$11M | |
| REZI - Resideo Technologies | Reduce −5.9% | 1,477,863 | $16.45 | $24M | −92,220 | −$6M | |
| PKG - Graphic Packaging | Add +28.3% | 1,067,670 | $22.25 | $24M | +235,400 | +$7M | |
| VSXY - Victorias Secret And | Reduce −40.0% | 411,071 | $35.78 | $15M | −273,610 | −$5M | |
| GPRO - Gopro · CL A | Reduce −1.2% | 2,665,140 | $4.98 | $13M | −32,060 | −$25K | |
| CNXC - Concentrix | Reduce −13.1% | 96,021 | $133.16 | $13M | −14,446 | +$454K | |
| GPOR - Gulfport Energy | New | 125,500 | $73.64 | $9M | +125,500 | +$9M | |
| LKFT - Galapagos | Add +6.1% | 155,358 | $44.38 | $7M | +8,970 | +$653K | |
| Funko · CL A | New | 521,500 | $10.91 | $6M | +521,500 | +$6M | |
| Danimer Scientific · CL A | Add +16.9% | 2,250,000 | $1.79 | $4M | +325,060 | −$2M | |
| CNX - Cnx Res | Reduce −2.9% | 216,165 | $16.84 | $4M | −6,550 | +$182K | |
| Waverley Capital Acquis | Hold | 350,000 | $10.01 | $4M | — | — | |
| Finserv Acquisition Ii | Hold | 315,000 | $10.03 | $3M | — | — | |
| Panacea Acquisition Ii · CL A | Hold | 275,000 | $10.05 | $3M | — | — | |
| COYA - Coya Therapeutics | New | 392,444 | $4.74 | $2M | +392,444 | +$2M | |
| GANX - Gain Therapeutics | Hold | 546,560 | $3.13 | $2M | — | — | |
| Talis Biomedical | Hold | 2,235,783 | $0.4457 | $996K | — | — | |
| Neubase Therapeutics | Hold | 2,727,027 | $0.1902 | $519K | — | — | |
| Polestar Automotive UK | Hold | 82,100 | $1.12 | $92K | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $1.92 | $67K | — | — | |
| 23andme · CLASS A | Hold | 23,591 | $2.16 | $51K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2022 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Exit | 0 | $43.84 | $188M | −4,288,500 | −$188M | ||
| Change Healthcare | Exit | 0 | $27.49 | $22M | −801,701 | −$22M | |
| INTC - Intel | Exit | 0 | $25.77 | $18M | −715,000 | −$18M | |
| NWSA - NEWS · CL B | Exit | 0 | $15.42 | $6M | −361,291 | −$6M | |
| RIVN - Rivian Automotive · CL A | Exit | 0 | $32.92 | $2M | −73,723 | −$2M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2